Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to -$1.2 billion.

  • Viridian Therapeutics, Inc.\DE's Retained Earnings fell 3296.15% to -$1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 billion, marking a year-over-year decrease of 3296.15%. This contributed to the annual value of -$995.9 million for FY2024, which is 3718.78% down from last year.
  • Viridian Therapeutics, Inc.\DE's Retained Earnings amounted to -$1.2 billion in Q3 2025, which was down 3296.15% from -$1.2 billion recorded in Q2 2025.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Retained Earnings peaked at -$297.3 million during Q1 2021, and registered a low of -$1.2 billion during Q3 2025.
  • Its 5-year average for Retained Earnings is -$662.7 million, with a median of -$611.4 million in 2023.
  • The largest annual percentage gain for Viridian Therapeutics, Inc.\DE's Retained Earnings in the last 5 years was 2847.5% (2021), contrasted with its biggest fall of 7507.77% (2021).
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Retained Earnings (Quarter) stood at -$358.3 million in 2021, then plummeted by 36.25% to -$488.2 million in 2022, then tumbled by 48.7% to -$725.9 million in 2023, then tumbled by 37.19% to -$995.9 million in 2024, then dropped by 22.32% to -$1.2 billion in 2025.
  • Its last three reported values are -$1.2 billion in Q3 2025, -$1.2 billion for Q2 2025, and -$1.1 billion during Q1 2025.